Baker Bros. Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Baker Bros. Advisors’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,559,231	Closed	-$13.7M	–	117
2019 Q3	$13.7M	Hold	1,559,231	–	–	0.09%	47
2019 Q2	$14.4M	Buy	1,559,231 +1,053,991	+209%	+$7.94M	0.1%	44
2019 Q1	$3.25M	Buy	505,240 +350,565	+227%	+$2.28M	0.02%	68
2018 Q4	$1.46M	Hold	154,675	–	–	0.01%	80
2018 Q3	$3.11M	Hold	154,675	–	–	0.02%	83
2018 Q2	$4.51M	Hold	154,675	–	–	0.03%	78
2018 Q1	$4.61M	Hold	154,675	–	–	0.04%	78
2017 Q4	$4.98M	Hold	154,675	–	–	0.04%	78
2017 Q3	$5.38M	Sell	154,675 -350,057	-69%	-$11.3M	0.04%	76
2017 Q2	$15M	Buy	504,732 +125,598	+33%	+$3.6M	0.13%	39
2017 Q1	$11.3M	Buy	379,134 +365,388	+2,658%	+$9.33M	0.09%	48
2016 Q4	$241K	Hold	13,746	–	–	﹤0.01%	131
2016 Q3	$327K	Hold	13,746	–	–	﹤0.01%	131
2016 Q2	$220K	Hold	13,746	–	–	﹤0.01%	133
2016 Q1	$287K	Hold	13,746	–	–	﹤0.01%	129
2015 Q4	$371K	Sell	13,746 -398,262	-97%	-$10.9M	﹤0.01%	130
2015 Q3	$11.4M	Hold	412,008	–	–	0.11%	59
2015 Q2	$10.1M	Hold	412,008	–	–	0.09%	62
2015 Q1	$7.54M	Sell	412,008 -9,623	-2%	-$195K	0.06%	66
2014 Q4	$7.78M	Hold	421,631	–	–	0.08%	56
2014 Q3	$4.05M	Buy	421,631 +200,000	+90%	+$1.99M	0.05%	70
2014 Q2	$2.04M	Hold	221,631	–	–	0.02%	89
2014 Q1	$2.39M	Buy	+221,631	New	+$2.17M	0.03%	85

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Baker Bros. Advisors's LJPC Position: Q4 2019 in Review

Baker Bros. Advisors sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2019, closing a stake of 1,559,231 shares — an estimated $13.7M sold.

Baker Bros. Advisors first reported a position in LJPC in Q1 2014 and held it in 23 quarters. The position peaked at $15M in Q2 2017. 77 funds tracked by Wall St. Rank hold LJPC as of Q4 2019.

Baker Bros. Advisors reported no remaining La Jolla Pharmaceutical Company position as of Q4 2019 after selling out during the quarter.
Baker Bros. Advisors sold 1,559,231 La Jolla Pharmaceutical Company shares in Q4 2019, an estimated $13.7M.
Baker Bros. Advisors first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 23 quarters.
Baker Bros. Advisors's La Jolla Pharmaceutical Company position peaked at $15M in Q2 2017.
77 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2019.

Based on Baker Bros. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.